In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


reinnervate Ltd.

Latest From reinnervate Ltd.

Biogelx Ltd.

Cultured cells are important for learning about the basic biology of health and disease, for in vitro testing of new drugs, and potentially for the growing field of regenerative medicine, but flat sheets of cells grown in Petri dishes do not reflect the complexity of tissues in the human body. Biogelx Ltd. aims to meet this need by creating hydrogel scaffolds that mimic the cell growth environment in tissues and organs, and are specifically tailored to match each cell type.


reinnervate Ltd.

reinnervate Ltd. is commercializing Alvetex, a three-dimensional scaffold for cell culture. By supporting cell cultures that are more representative of the original tissues, Alvetex cultures could help drug companies fail drugs at an earlier stage, and could reduce the numbers of animals required in testing, thereby saving money in drug development.


Start-Up Previews (07/2010)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads," features profiles of AlzProtect, Axerion Therapeutics, Cognition Therapeutics and Galantos Pharma. "The Future of Laparoscopy: Single Incision, NOTES And Robots," features profiles of EndoControl, Ovesco Endoscopy, SurgiQuest and Virtual Incision. Plus these Start-Ups Across Health Care: Antabio, Beta-Stim, CMP Therapeutics, Elixir Medical, Kerecis, Optivia Biotechnology, Quanterix and reinnervate.

See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • reinnervate Ltd.
  • Senior Management
  • Ashley Cooper, CEO
    David Blain, CFO
    Stefan Przyborski, PhD, CSO
  • Contact Info
  • reinnervate Ltd.
    Phone: (44) 191 3343988
    Thomas Wright Way
    Sedgefield, TS21 3FD